Displaying items by tag: division of hematology and oncology

A UAB oncologist’s research shows that health care clinic closures could result in an increase in Medicare spending, which could negatively affect rural communities.
Findings indicated that sociodemographic disparities play a factor in whether all children are receiving high-quality and/or end-of-life care consistent with their goals.
Checkpoint inhibitors are types of cancer-fighting drugs that can help block proteins made by certain immune system cells, such as T cells.
UAB’s Division of Hematology and Oncology has named a new director of a key patient clinic.
End-of-life care can be difficult to navigate, but understanding how to treat a patient based on their goals is key, says one UAB researcher.
The UAB hematology nursing staff pulled out all the stops to help a patient and her partner celebrate their love for each other while in the hospital.
The UAB-led clinical trial intends to provide multiple myeloma patients a treatment plan that eradicates their disease and enables them to live a life without ongoing treatment.
An assistant professor in UAB’s Division of Hematology and Oncology receives achievement award from her alma mater.
A study regarding health risks in colorectal cancer patients may help develop personalized therapeutic options for patients with pre-existing morbidities.
UAB researchers have determined that recipients are likely to experience cognitive impairment in years following treatment.
Page 3 of 6